These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 1936894
1. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats. Cohen MP, Klepser H, Wu VY. Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894 [Abstract] [Full Text] [Related]
5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG. Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023 [Abstract] [Full Text] [Related]
6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Beyer-Mears A, Ku L, Cohen MP. Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041 [Abstract] [Full Text] [Related]
7. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies. Kassab JP, Guillot R, Andre J, Claperon N, Bellon G, Feldmann G, Peyroux J, Sternberg M. Biochem Pharmacol; 1994 Aug 30; 48(5):1003-8. PubMed ID: 8093087 [Abstract] [Full Text] [Related]
9. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli. Cohen MP, Klepser H, Cua E. Biochim Biophys Acta; 1986 Apr 15; 876(2):226-32. PubMed ID: 3006784 [Abstract] [Full Text] [Related]
10. L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats. Jyothirmayi GN, Modak R, Reddi AS. Nephron; 2001 Feb 15; 87(2):148-54. PubMed ID: 11244310 [Abstract] [Full Text] [Related]
11. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Bank N, Mower P, Aynedjian HS, Wilkes BM, Silverman S. Am J Physiol; 1989 Jun 15; 256(6 Pt 2):F1000-6. PubMed ID: 2500028 [Abstract] [Full Text] [Related]
12. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats. Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR. J Diabet Complications; 1991 Jun 15; 5(4):230-7. PubMed ID: 1779018 [Abstract] [Full Text] [Related]
13. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor. Das A, Frank RN, Zhang NL, Samadani E. Exp Eye Res; 1990 Mar 15; 50(3):269-80. PubMed ID: 2108050 [Abstract] [Full Text] [Related]
14. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat. Das A, Frank RN, Zhang NL. Diabetologia; 1990 Sep 15; 33(9):515-21. PubMed ID: 2123806 [Abstract] [Full Text] [Related]
15. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition. Cohen MP, Klepser H. Diabetes; 1988 May 15; 37(5):558-62. PubMed ID: 2834250 [Abstract] [Full Text] [Related]
16. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy. Cohen M. Diabet Med; 1985 May 15; 2(3):203-6. PubMed ID: 3032499 [No Abstract] [Full Text] [Related]
18. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil. Whiting PH, Ross IS. Br J Exp Pathol; 1988 Oct 15; 69(5):697-702. PubMed ID: 3143396 [Abstract] [Full Text] [Related]
19. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Cohen MP, Klepser H, Wu VY. Diabetes; 1988 Oct 15; 37(10):1324-7. PubMed ID: 2970980 [Abstract] [Full Text] [Related]